Biologics FibroBiologics Presents Preclinical Data on Fibroblast Spheroid-Derived Chondrocyte Spheroids for Degenerative Disc Disease at the North American Spine Society 2026 Annual Meeting byWill SandbergOctober 19, 2026
Financial Spine Degenerative Disc Disease Treatment Market is Expected to Reach Revenue of USD 66.2 Bn by 2033, at 7.7% CAGR: Dimension Market Research byTim AllenOctober 8, 2024
Regulatory Spine FDA Grants Breakthrough Device Designation to ORTHOSON’s Bio-Structural Gel byJosh SandbergFebruary 8, 2024
Financial Spine Degenerative Disc Disease Market Size to Grow by USD 1.03 billion, Launch of Innovative Products to be a Key Trend – Technavio byJosh SandbergSeptember 27, 2022
Spine Top Stories DiscGenics Announces Presentation of Positive Interim Clinical Data from Phase 1/2 Study of Cell Therapy for Degenerative Disc Disease byJosh SandbergFebruary 25, 2022
Spine Aurora Spine Plans A Major Multicenter Study of its ZIP™ Interspinous Fixation Device for Relief of Back Pain byChris StewartDecember 17, 2020
Spine CoreLink Introduces Oro Lateral Plate System Designed for Optimum Versatility to Treat Patients Suffering From Spinal Conditions byJosh SandbergSeptember 18, 2019
Spine Top Stories Nocimed Announces First Commercial Clients for New Non-Invasive Spinal Pain Assessment Tool In North America and Europe byJosh SandbergSeptember 17, 2019
Biologics Spine Kuros Biosciences Announces U.S. FDA approval of IND Application to Initiate Fibrin-PTH Phase 2a Clinical Trial in Spinal Fusion byJosh SandbergSeptember 3, 2019
Spine Top Stories Nocimed Announces Publication of Using Magnetic Resonance Spectroscopy to Identify Painful Lumbar Discs in the European Spine Journal byJosh SandbergAugust 23, 2019
